Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KYTXthis companyKyverna Therapeutics, Inc.	$5.08	-2.58×	1.79×	0×	-2.02×	-60.9%	0.0%	0.0%	0.0%	-69.4%	-65.0%	-36.9%	0.12×	0.6×	-347.29×	7.75×	0.0%	1	-0.9	2	C
ALLOAllogene Therapeutics, Inc.	$1.02	-1.57×	1.03×	0×	-1.88×	-114.2%	0.0%	0.0%	0.0%	-65.3%	-52.8%	-49.5%	0.28×	-0.18×	-192.5×	7.93×	0.0%	4	-3.65	2	C
AVIRAtea Pharmaceuticals, Inc.	$4.40	-1.84×	1.06×	0×	-1.19×	-75.3%	0.0%	0.0%	0.0%	-57.5%	-63.0%	-45.4%	0×	0.58×	0×	7.82×	0.0%	2	1.99	3	B-
CABACabaletta Bio, Inc.	$1.47	-1.34×	2×	0×	-1.02×	-65.7%	0.0%	0.0%	0.0%	-149.8%	-123.8%	-59.1%	0.24×	0.34×	-85.95×	2.77×	0.0%	2	-1.41	2	C+
CAPRCapricor Therapeutics, Inc.	$9.10	-12.77×	4.39×	0×	-10.7×	-20.2%	0.0%	0.0%	0.0%	-34.4%	-33.4%	-5.4%	0.06×	2.7×	-35.51×	9.01×	0.0%	2	0.16	2	C
CTNMContineum Therapeutics, Inc.	$10.02	-5.27×	1.21×	0×	-3.68×	-74.9%	0.0%	0.0%	0.0%	-23.0%	-25.3%	-17.5%	0.03×	0.99×	0×	27.5×	0.0%	2	16.76	2	C+
Peer median	—	-1.84×	1.21×	0×	-1.88×	-74.9%	0.0%	0.0%	0.0%	-57.5%	-52.8%	-45.4%	0.06×	0.58×	-35.51×	7.93×	0.0%	2	0.16	2	—